Pomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 1 and 2 trial
Vaishali Sanchorawala(Boston University), David C. Seldin(Boston University), Cindy Varga, Stephen Lo, Anthony C Shelton, J. Mark Sloan(Boston University)
Cited by 274
Related Papers
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
|Annals of Internal Medicine|2004|615
Systemic immunoglobulin light chain amyloidosis
|Nature Reviews Disease Primers|2018|550
Amyloidosis: Pathogenesis and New Therapeutic Options
|Journal of Clinical Oncology|2011|508